40 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceutical Industries Limited (TEVA) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/07/teva-pharmaceutical-industries-limited-teva-q3-201.aspx?source=iedfolrf0000001 Nov 07, 2019 - TEVA earnings call for the period ending September 30, 2019.
Teva Pharmaceutical Industries Limited 2019 Q3 - Results - Earnings Call Presentation https://seekingalpha.com/article/4304322-teva-pharmaceutical-industries-limited-2019-q3-results-earnings-call-presentation?source=feed_tag_israel Nov 08, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q3 earnings call.
Why It Is Time To Load Up On Teva Stock https://seekingalpha.com/article/4305975-time-load-teva-stock?source=feed_tag_israel Nov 12, 2019 - Investors responded favorably to Teva's third-quarter earnings report.Litigation risks dissipating.Strong pipeline, initial sales of new drugs, and more.
Teva prices upsized $2.1B debt offering https://seekingalpha.com/news/3520567-teva-prices-upsized-2_1b-debt-offering?source=feed_news_all Nov 19, 2019 -
Teva inks early-stage drug research deals https://seekingalpha.com/news/3521812-teva-inks-early-stage-drug-research-deals?source=feed_news_all Nov 25, 2019 - Teva (NYSE:TEVA) is starting the week up 5.6% after signing research agreements with two leading Israeli academic institutes to boost its early-stage drug development.A partnership with Tel Aviv Unive
Why The Bear Attack On Teva Pharmaceutical Must End https://seekingalpha.com/article/4309342-bear-attack-teva-pharmaceutical-must-end?source=feed_tag_israel Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
Why The Bear Attack On Teva Pharmaceutical Must End https://seekingalpha.com/article/4309342-why-bear-attack-on-teva-pharmaceutical-must-end?source=feed_tag_israel Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders http://www.zacks.com/stock/news/653885/jjs-jnj-new-tests-reveal-no-asbestos-in-baby-powders?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-653885 Dec 04, 2019 - J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
Bayer and Teva Double Down on Worst M&A Deals of Decade http://www.gurufocus.com/news/995213/bayer-and-teva-double-down-on-worst-ma-deals-of-decade Dec 04, 2019 - Bayer and Teva Double Down on Worst M&A Deals of Decade, Stocks: BAYN,TEVA,GILD,MRK,NVS,BMY,PFE,GSK,SHRS,SNY,AMGN,A, release date:Dec 03, 2019
Teva Pharmaceutical Industries Ltd. (TEVA) Outpaces Stock Market Gains: What You Should Know http://www.zacks.com/stock/news/678945/teva-pharmaceutical-industries-ltd-teva-outpaces-stock-market-gains-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-678945 Dec 19, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $9.97, moving +1.73% from the previous trading session.

Pages: 1234

Page 1>